Omeros - 53 Year Dividend History | OMER
Historical dividend payout and yield for Omeros (OMER) since 1971. The current TTM dividend payout for Omeros (OMER) as of December 20, 2024 is $0.00. The current dividend yield for Omeros as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Products Manufacturing |
$0.593B |
$0.000B |
|
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
